275 related articles for article (PubMed ID: 19276294)
21. Painful blistered hands and feet.
Coyle C; Wenhold V
Clin J Oncol Nurs; 2001; 5(5):230-2. PubMed ID: 11899771
[TBL] [Abstract][Full Text] [Related]
22. [Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases].
Hueso L; Sanmartín O; Nagore E; Botella-Estrada R; Requena C; Llombart B; Serra-Guillén C; Alfaro-Rubio A; Guillén C
Actas Dermosifiliogr; 2008 May; 99(4):281-90. PubMed ID: 18394404
[TBL] [Abstract][Full Text] [Related]
23. Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death.
Zimmerman EI; Gibson AA; Hu S; Vasilyeva A; Orwick SJ; Du G; Mascara GP; Ong SS; Chen T; Vogel P; Inaba H; Maitland ML; Sparreboom A; Baker SD
Cancer Res; 2016 Jan; 76(1):117-26. PubMed ID: 26677977
[TBL] [Abstract][Full Text] [Related]
24. [Palmoplantar cutaneous reaction to sorafenib].
Echeverría B; Llombart B; Botella-Estrada R; Guillén C
Actas Dermosifiliogr; 2009 Oct; 100(8):736-7. PubMed ID: 19775561
[No Abstract] [Full Text] [Related]
25. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
Webster-Gandy JD; How C; Harrold K
Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
[TBL] [Abstract][Full Text] [Related]
26. The Efficacy and Safety of the Shouzu Ning Decoction Treatment for Multi-Kinase Inhibitors-Associated Severe Hand-Foot Skin Reaction.
Shou L; Shao T; Zhao F; Chen S; Chen Q; Shu Q
Cancer Manag Res; 2021; 13():45-53. PubMed ID: 33442293
[TBL] [Abstract][Full Text] [Related]
27. [A man with blisters on hand and feet].
Gelderblom AJ; van der Rhee JI; Ouwerkerk J
Ned Tijdschr Geneeskd; 2011; 155(45):A3994. PubMed ID: 22085574
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide in multikinase inhibitor-induced hand-foot skin reaction.
Chen L; Wu Z; Yang L; Chen Y; Wang W; Cheng L; Li C; Lv D; Xia L; Chen J; Tang L; Zhang LI; Zhang S; Luo J
Transl Res; 2022 Jul; 245():82-98. PubMed ID: 35189405
[TBL] [Abstract][Full Text] [Related]
29. Clinical approaches to minimize rash associated with EGFR inhibitors.
Oishi K
Oncol Nurs Forum; 2008 Jan; 35(1):103-11. PubMed ID: 18192159
[TBL] [Abstract][Full Text] [Related]
30. Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management.
Ai L; Xu Z; Yang B; He Q; Luo P
Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1121-1127. PubMed ID: 31679411
[No Abstract] [Full Text] [Related]
31. Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials.
Pandy JGP; Franco PIG; Li RK
Support Care Cancer; 2022 Nov; 30(11):8655-8666. PubMed ID: 35655045
[TBL] [Abstract][Full Text] [Related]
32. The Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for Oncology.
Anderson RT; Keating KN; Doll HA; Camacho F
Oncologist; 2015 Jul; 20(7):831-8. PubMed ID: 26084809
[TBL] [Abstract][Full Text] [Related]
33. What kind of rash is it?: deciphering the dermatologic toxicities of biologic and targeted therapies.
Esper P; Gale D; Muehlbauer P
Clin J Oncol Nurs; 2007 Oct; 11(5):659-66. PubMed ID: 17962174
[TBL] [Abstract][Full Text] [Related]
34. [Cutaneous adverse reaction to carbamazepine: unusual presentation].
Duarte AF; Baudrier T; Mota A; Azevedo F
Acta Med Port; 2010; 23(2):267-72. PubMed ID: 20470476
[TBL] [Abstract][Full Text] [Related]
35. Dermatologic symptoms associated with the multikinase inhibitor sorafenib.
Robert C; Mateus C; Spatz A; Wechsler J; Escudier B
J Am Acad Dermatol; 2009 Feb; 60(2):299-305. PubMed ID: 19028406
[TBL] [Abstract][Full Text] [Related]
36. Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management.
Nagore E; Insa A; Sanmartín O
Am J Clin Dermatol; 2000; 1(4):225-34. PubMed ID: 11702367
[TBL] [Abstract][Full Text] [Related]
37. Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor.
Battistella M; Frémont G; Vignon-Pennamen MD; Gornet JM; Dubertret L; Viguier M
Arch Dermatol; 2008 Oct; 144(10):1400-2. PubMed ID: 18936416
[No Abstract] [Full Text] [Related]
38. Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis.
Belum VR; Serna-Tamayo C; Wu S; Lacouture ME
Clin Exp Dermatol; 2016 Jan; 41(1):8-15. PubMed ID: 26009777
[TBL] [Abstract][Full Text] [Related]
39. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
Manchikanti L; Datta S; Smith HS; Hirsch JA
Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
[TBL] [Abstract][Full Text] [Related]
40. Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?
Yen-Revollo JL; Goldberg RM; McLeod HL
Clin Cancer Res; 2008 Jan; 14(1):8-13. PubMed ID: 18172246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
